Discover a study where results suggest a statistically significant association between dupilumab and psoriasis, although the clinical impact may be limited.

Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

A new study published in the Journal of American Medical Association showed that dupilumab (Dupixent), used for treating ...

Bio-Thera Solutions and SteinCares have signed a new agreement to commercialize a proposed biosimilar of dupilumab across ...

The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...

Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia, breaks down how to communicate the value of ...

The Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Biological drugs have improved the lives of many people with severe asthma. However, a new study from Karolinska Institutet ...

"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

Biological drugs have been a game-changer for people with severe asthma, helping them breathe easier and live more ...